USA funding for pharmaceutical supply chain survey in Egypt

26 August 2010

Egypt has received a grant of over half a million dollars from the USA that will fund a study on how to decrease the price of pharmaceuticals and increase their availability in the local market, reports Zawya, Daily News Egypt. US Ambassador to Egypt Margaret Scobey and Kamal Sabra, Assistant Minister of Health for pharmaceutical affairs, recently signed a cooperative agreement for the $557,704 grant.

The grant, signed by Ms Scobey on behalf of the US Trade Development Agency (USTDA), will fund a feasibility study on how to enhance Egypt's pharmaceuticals supply chain to meet growing needs. Egypt's health care sector is expecting growth rates of 10 percent annually for the next five years.

According to a statement by the US Department of State, the study focuses on possibilities for data collection, inventory management and process standardization, and is "an integral part of the Ministry's health reform effort to provide cost-effective and improved services to the public." Expanding the capabilities of the current supply chain will lead to lower costs and a greater variety of pharmaceuticals available to patients, the statement read. The project will fund two pilot projects in two governorates to test key findings of the study.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical